Massive typhoid vaccine trial shows promise in High-Risk indian city
NCT ID NCT05500482
First seen Mar 27, 2026 · Last updated May 13, 2026 · Updated 9 times
Summary
This study tested a typhoid vaccine called TyphiBEV in over 72,000 people aged 1 to 30 in Vellore, India, a city with high typhoid rates. Researchers compared typhoid cases in vaccinated groups versus unvaccinated groups to see if the vaccine reduces infections. The goal is to understand how well the vaccine works in real-world conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPHOID FEVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Christian Medical College Vellore
Vellore, Tamil Nadu, 632002, India
Conditions
Explore the condition pages connected to this study.